Medical School
- MD, University of Colorado School of Medicine (2018)
Graduate School
- PhD, University of Colorado School of Medicine (2016)
Undergraduate School
- BS, Rice University (TX)
Residency
- Stanford Hospital and Clinics Program, Pathology (2022)
Fellowships
- Stanford Hospital and Clinics Program, Hematology (2023)
Department
PathologyPublications
- USCAP 2026: WHO5 TP53 allelic state configuration is relevant in patients with TP53 mutated myeloid neoplasms receiving hypomethylating agent (HMA)-based regimens: Interim report of the International TP53 investigators Network (iTIN)
- USCAP 2026: The 20% Blast Count Threshold is Relevant in Patients with TP53-Mutated Myeloid Neoplasm Receiving Frontline Hypomethylating Agent Based Therapies.
- USCAP 2026: Clinicopathologic and Molecular Features of Biclonal Chronic Lymphocytic Leukemia: A Single-Institution Series of 7 Cases
- USCAP 2026: Acute Erythroid Leukemia Clonally Evolved from Myeloid Neoplasms
- USCAP 2026: Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-cell Lymphoproliferative Disorders
- Nazmul Islam, Justin L. Dale, Jamie S. Reuben, Karan Sapiah, James W. Coates, Frank R. Markson, Jingjing Zhang, Lezhou Wu, Maura Gasparetto, Brett M. Stevens, Sarah E. Staggs, William M. Showers, Monica R. Ransom, Jairav Desai, Ujjwal V. Kulkarni, Krysta L. Engel, Craig T. Jordan, Michael Boyiadzis, Clayton A. Smith. Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine. JCO Clin Cancer Inform 9, e2400308(2025). DOI:10.1200/CCI-24-00308
- Zhang J, Bulterys PL, Fernandez-Pol S, Younes SF, Zhao S, Mansoor A, Natkunam Y. Expression of CD47 protein in hematolymphoid neoplasms: Implications for CD47-mediated cancer immunotherapy. Am J Clin Pathol. 2025 Jun 3;163(6):883-897. PubMed PMID: 40072022
- Gisriel SD, Yuan J, Tang H, Xu J, Fang H, Li S, McCracken J, Li P, Braunberger RC, Xu-Monette ZY, Wu X, Wang E, Zhang QY, Soma LA, Katz SG, Zhang JJ, Matsumoto NP, Young KH, Xu ML, Pan Z. Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study. Am J Clin Pathol. 2025 Sep 9;164(3):390-401. PubMed PMID: 40581918
- Pollyea DA, Stevens BM, Abbott D, Amaya M, Gutman JA, Kent A, McMahon C, Schwartz M, Smith C, Dell-Martin J, Sohalski C, Ellis A, Haag M, Schowinsky J, Pan Z, Patel SB, Ransom M, Gillen A, Jordan CT, Pietras EM. Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial. EClinicalMedicine. 2025 Nov;89:103546. PubMed PMID: 41140451
- Alnoor F, Spies NC, Kumar J, Samghabadi P, Silva O, Luo MX, Chisholm KM, Zhang J, Rangel A, Ng D, Li P, Ohgami RS. The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease. Am J Hematol. 2025 Nov;100(11):2064-2073. PubMed PMID: 40838678
- Gilbert JS, Connor M, Bosma G, Zhang J, McMahon CM, Amaya ML, Gutman J, Schwartz M, Kent A, Abbott D, Pollyea DA. Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis. Am J Hematol. 2025 Nov;100(11):2140-2143. PubMed PMID: 40810378
- Pandiri M, Stengel A, Zhang J, Wang P, Shao H, Velmurugan S, Jacob A, Symes E, Kaur A, Rojek A, Sojitra P, Wiredja D, Zhou Q, Chang H, Patil E, Patel JL, Patel AB, Menon M, Ghosh S, Wool GD, Arber DA, Pan Z, Findley A, Badar T, Tariq H, Sallman D, Bell RC, Perry A, Haferlach C, Fitzpatrick C, Venkataraman G. Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. J Clin Pathol. 2025 Aug 18;78(9):629-635. PubMed PMID: 40571403
- Wadsworth P, Zhang J, Miller T, Menke J, Oak J, Fernandez-Pol S. Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry. Leuk Lymphoma. 2024 Sep;65(9):1374-1377. PubMed PMID: 38747176
- Symes EO, Wang P, Sojitra P, Menon MP, Patel AA, Hasan F, Ghosh S, Roloff GW, Zhou Q, Findley A, Badar T, Zhang J, Tariq H, Chang H, Bell RC, Perry AM, Venkataraman G. Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms. Br J Haematol. 2024 Nov 17. [Epub ahead of print] PubMed PMID: 39551719
- Zhou X, Zhang J. EBV-positive inflammatory follicular dendritic cell sarcoma, an entity by many names. Br J Haematol. 2024 Nov 19. [Epub ahead of print] PubMed PMID: 39562822
- Zhang, J., Tan, B. & Fernandez-Pol, S. Lupus erythematosus cells in a bone marrow aspirate. J Hematopathol 16, 247–248 (2023). https://doi.org/10.1007/s12308-023-00561-8
Practice Locations
UCHealth University of Colorado Hospital (UCH)12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties- Anatomic and Clinical, Board Certification
- Hematology, Board Certification